- Filed
- May 1, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 27, 2026 | 15.96M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 14.21M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 11.67M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $164.95M |
| Capex | Q1 2026 · Mar 31, 2025 | $164.95M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $113.34M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $87.74M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $2.12B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $2.12B |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $46K |
| Short Term Investments | Q1 2026 · Dec 31, 2025 | $31K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $500.81M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $940.71M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2025 | $396.47M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2024 | $389.65M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $568.94M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $590.73M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $585.22M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $993M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.94B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $3.35B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $1.15B |
| Current Assets | Q1 2026 · Dec 31, 2025 | $1.55B |
| Total Assets | Q1 2026 · Mar 31, 2026 | $4.39B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $4.79B |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$1.54 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $2.18 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$1.54 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $2.35 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $71.76M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $68.51M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $13.51M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $14.04M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$15.17M |
| Net Income | Q1 2026 · Mar 31, 2025 | $32.99M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $95.37M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $101.81M |
| Revenue | Q1 2026 · Mar 31, 2026 | $783.55M |
| Revenue | Q1 2026 · Mar 31, 2025 | $736.19M |